Detalhe da pesquisa
1.
Tumor-reactive antibodies evolve from non-binding and autoreactive precursors.
Cell
; 185(7): 1208-1222.e21, 2022 03 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-35305314
2.
Redifferentiated cardiomyocytes retain residual dedifferentiation signatures and are protected against ischemic injury.
Nat Cardiovasc Res
; 2(4): 383-398, 2023 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-37974970